FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016216936> ?p ?o ?g. }

• W3016216936 endingPage "108088" @default.
• W3016216936 startingPage "108088" @default.
• W3016216936 abstract "The interaction between apoptosis-inducing factor (AIF) and cyclophilin A (CypA) has been shown to contribute to caspase-independent apoptosis. Blocking the AIF/CypA interaction protects against glutamate-induced neuronal cell death in vitro, and the purpose of this study was to determine the in vivo effect of an AIF/CypA interaction blocking peptide (AIF(370-394)-TAT) on neonatal mouse brain injury after hypoxia-ischemia (HI). The pups were treated with AIF (370-394)-TAT peptide intranasally prior to HI. Brain injury was significantly reduced at 72 h after HI in the AIF(370-394)-TAT peptide treatment group compared to vehicle-only treatment for both the gray matter and the subcortical white matter, and the neuroprotection was more pronounced in males than in females. Neuronal cell death was evaluated in males at 8 h and 24 h post-HI, and it was decreased significantly in the CA1 region of the hippocampus and the nucleus habenularis region after AIF(370-394)-TAT treatment. Caspase-independent apoptosis was decreased in the cortex, striatum, and nucleus habenularis after AIF(370-394)-TAT treatment, but no significant change was found on caspase-dependent apoptosis as indicated by the number of active caspase-3-labeled cells. Further analysis showed that both AIF and CypA nuclear accumulation were decreased after treatment with the AIF(370-394)-TAT peptide. These results suggest that AIF(370-394)-TAT inhibited AIF/CypA translocation to the nucleus and reduced HI-induced caspase-independent apoptosis and brain injury in young male mice, suggesting that blocking AIF/CypA might be a potential therapeutic target for neonatal brain injury." @default.
• W3016216936 created "2020-04-17" @default.
• W3016216936 creator A5004853365 @default.
• W3016216936 creator A5005834061 @default.
• W3016216936 creator A5006930310 @default.
• W3016216936 creator A5009019549 @default.
• W3016216936 creator A5011355109 @default.
• W3016216936 creator A5026857251 @default.
• W3016216936 creator A5030623189 @default.
• W3016216936 creator A5035417850 @default.
• W3016216936 creator A5048012256 @default.
• W3016216936 creator A5066102428 @default.
• W3016216936 creator A5068054602 @default.
• W3016216936 creator A5084869463 @default.
• W3016216936 creator A5086124785 @default.
• W3016216936 creator A5087278987 @default.
• W3016216936 creator A5091792799 @default.
• W3016216936 date "2020-07-01" @default.
• W3016216936 modified "2023-10-15" @default.
• W3016216936 title "Inhibiting the interaction between apoptosis-inducing factor and cyclophilin A prevents brain injury in neonatal mice after hypoxia-ischemia" @default.
• W3016216936 cites W1901072277 @default.
• W3016216936 cites W1966928113 @default.
• W3016216936 cites W1972404513 @default.
• W3016216936 cites W1975569298 @default.
• W3016216936 cites W1976545164 @default.
• W3016216936 cites W2004198397 @default.
• W3016216936 cites W2014202579 @default.
• W3016216936 cites W2023997512 @default.
• W3016216936 cites W2027014741 @default.
• W3016216936 cites W2032413974 @default.
• W3016216936 cites W2034268376 @default.
• W3016216936 cites W2046637240 @default.
• W3016216936 cites W2072455450 @default.
• W3016216936 cites W2073108532 @default.
• W3016216936 cites W2074194694 @default.
• W3016216936 cites W2074573663 @default.
• W3016216936 cites W2075026191 @default.
• W3016216936 cites W2085641738 @default.
• W3016216936 cites W2095427825 @default.
• W3016216936 cites W2106565664 @default.
• W3016216936 cites W2110593253 @default.
• W3016216936 cites W2111855922 @default.
• W3016216936 cites W2123981897 @default.
• W3016216936 cites W2153446990 @default.
• W3016216936 cites W2158213789 @default.
• W3016216936 cites W2163427959 @default.
• W3016216936 cites W2164461155 @default.
• W3016216936 cites W2168418128 @default.
• W3016216936 cites W2171174186 @default.
• W3016216936 cites W2232187600 @default.
• W3016216936 cites W2274307653 @default.
• W3016216936 cites W2342987015 @default.
• W3016216936 cites W2396543304 @default.
• W3016216936 cites W2549697535 @default.
• W3016216936 cites W2607336935 @default.
• W3016216936 cites W2612719840 @default.
• W3016216936 cites W2749470720 @default.
• W3016216936 cites W2781028825 @default.
• W3016216936 cites W2791608805 @default.
• W3016216936 cites W2793860077 @default.
• W3016216936 cites W2905165789 @default.
• W3016216936 cites W2913447468 @default.
• W3016216936 cites W2921916301 @default.
• W3016216936 cites W2949817554 @default.
• W3016216936 cites W3003182814 @default.
• W3016216936 doi "https://doi.org/10.1016/j.neuropharm.2020.108088" @default.
• W3016216936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32277944" @default.
• W3016216936 hasPublicationYear "2020" @default.
• W3016216936 type Work @default.
• W3016216936 sameAs 3016216936 @default.
• W3016216936 citedByCount "14" @default.
• W3016216936 countsByYear W30162169362020 @default.
• W3016216936 countsByYear W30162169362021 @default.
• W3016216936 countsByYear W30162169362022 @default.
• W3016216936 countsByYear W30162169362023 @default.
• W3016216936 crossrefType "journal-article" @default.
• W3016216936 hasAuthorship W3016216936A5004853365 @default.
• W3016216936 hasAuthorship W3016216936A5005834061 @default.
• W3016216936 hasAuthorship W3016216936A5006930310 @default.
• W3016216936 hasAuthorship W3016216936A5009019549 @default.
• W3016216936 hasAuthorship W3016216936A5011355109 @default.
• W3016216936 hasAuthorship W3016216936A5026857251 @default.
• W3016216936 hasAuthorship W3016216936A5030623189 @default.
• W3016216936 hasAuthorship W3016216936A5035417850 @default.
• W3016216936 hasAuthorship W3016216936A5048012256 @default.
• W3016216936 hasAuthorship W3016216936A5066102428 @default.
• W3016216936 hasAuthorship W3016216936A5068054602 @default.
• W3016216936 hasAuthorship W3016216936A5084869463 @default.
• W3016216936 hasAuthorship W3016216936A5086124785 @default.
• W3016216936 hasAuthorship W3016216936A5087278987 @default.
• W3016216936 hasAuthorship W3016216936A5091792799 @default.
• W3016216936 hasBestOaLocation W30162169361 @default.
• W3016216936 hasConcept C153911025 @default.
• W3016216936 hasConcept C172043667 @default.
• W3016216936 hasConcept C185592680 @default.
• W3016216936 hasConcept C190283241 @default.
• W3016216936 hasConcept C25498285 @default.
• W3016216936 hasConcept C2780778672 @default.

• next